State of Wisconsin Investment Board lowered its stake in Opko Health, Inc. (NASDAQ:OPK) by 63.2% during the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 64,243 shares of the biotechnology company’s stock after selling 110,336 shares during the period. State of Wisconsin Investment Board’s holdings in Opko Health were worth $514,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Capstone Asset Management Co. increased its stake in Opko Health by 8.6% in the first quarter. Capstone Asset Management Co. now owns 17,646 shares of the biotechnology company’s stock valued at $141,000 after buying an additional 1,400 shares during the last quarter. IFC Holdings Incorporated FL increased its stake in Opko Health by 15.9% in the first quarter. IFC Holdings Incorporated FL now owns 15,339 shares of the biotechnology company’s stock valued at $122,000 after buying an additional 2,100 shares during the last quarter. Baird Financial Group Inc. increased its stake in Opko Health by 5.1% in the fourth quarter. Baird Financial Group Inc. now owns 52,871 shares of the biotechnology company’s stock valued at $492,000 after buying an additional 2,558 shares during the last quarter. American Asset Management Inc. increased its stake in Opko Health by 8.8% in the first quarter. American Asset Management Inc. now owns 34,595 shares of the biotechnology company’s stock valued at $277,000 after buying an additional 2,800 shares during the last quarter. Finally, World Asset Management Inc increased its stake in Opko Health by 23.6% in the first quarter. World Asset Management Inc now owns 15,176 shares of the biotechnology company’s stock valued at $121,000 after buying an additional 2,900 shares during the last quarter. 23.66% of the stock is owned by institutional investors and hedge funds.

Institutional Ownership by Quarter for Opko Health (NASDAQ:OPK)

Shares of Opko Health, Inc. (OPK) opened at 6.53 on Friday. Opko Health, Inc. has a 12-month low of $5.99 and a 12-month high of $12.15. The stock’s market capitalization is $3.65 billion. The stock has a 50 day moving average price of $6.76 and a 200 day moving average price of $8.36.

Opko Health (NASDAQ:OPK) last posted its quarterly earnings results on Tuesday, May 9th. The biotechnology company reported ($0.06) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.04) by $0.02. The firm had revenue of $296.10 million during the quarter, compared to analyst estimates of $313.36 million. Opko Health had a negative return on equity of 2.13% and a negative net margin of 3.60%. The firm’s revenue for the quarter was up 1.8% on a year-over-year basis. During the same quarter last year, the business posted ($0.02) earnings per share. On average, equities analysts anticipate that Opko Health, Inc. will post ($0.20) earnings per share for the current fiscal year.

WARNING: This piece of content was originally reported by Financial Market News and is the sole property of of Financial Market News. If you are reading this piece of content on another site, it was illegally stolen and republished in violation of US and international copyright legislation. The correct version of this piece of content can be read at https://www.financial-market-news.com/2017/06/17/state-of-wisconsin-investment-board-has-514000-stake-in-opko-health-inc-opk.html.

OPK has been the subject of several research reports. Guggenheim initiated coverage on Opko Health in a report on Tuesday, March 14th. They issued a “buy” rating and a $25.00 target price for the company. Zacks Investment Research downgraded Opko Health from a “hold” rating to a “sell” rating in a report on Thursday, May 4th. Ladenburg Thalmann Financial Services reissued a “buy” rating and issued a $19.50 target price on shares of Opko Health in a report on Tuesday, June 6th. Standpoint Research reissued a “buy” rating and issued a $14.00 target price on shares of Opko Health in a report on Sunday, March 5th. Finally, Jefferies Group LLC reduced their target price on Opko Health from $10.00 to $8.00 and set a “hold” rating for the company in a report on Thursday, March 2nd. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and five have assigned a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $16.58.

In related news, Vice Chairman Jane Ph D. Hsiao bought 40,000 shares of the firm’s stock in a transaction on Wednesday, May 10th. The stock was bought at an average cost of $6.97 per share, for a total transaction of $278,800.00. Following the completion of the purchase, the insider now directly owns 24,723,133 shares in the company, valued at approximately $172,320,237.01. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Phillip Md Et Al Frost bought 207,700 shares of the firm’s stock in a transaction on Wednesday, May 31st. The stock was bought at an average price of $6.11 per share, with a total value of $1,269,047.00. Following the completion of the purchase, the chief executive officer now owns 3,068,951 shares of the company’s stock, valued at $18,751,290.61. The disclosure for this purchase can be found here. Over the last 90 days, insiders acquired 2,698,000 shares of company stock valued at $18,464,543. 40.74% of the stock is currently owned by insiders.

About Opko Health

OPKO Health, Inc is a healthcare company. Its segments include Pharmaceutical, Diagnostics and Corporate. Pharmaceutical consists of the pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain and its pharmaceutical research and development operations. Diagnostics consists of the clinical laboratory operations in Bio-Reference Laboratories (Bio-Reference) and its point-of-care operations.

Want to see what other hedge funds are holding OPK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Opko Health, Inc. (NASDAQ:OPK).

Receive News & Ratings for Opko Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Opko Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.